<DOC>
	<DOCNO>NCT00260000</DOCNO>
	<brief_summary>The main purpose test whether treatment BH4-tablets replace protein restrictive diet patient mild PKU cause certain frequent mutation .</brief_summary>
	<brief_title>Study BH4 , New Simple Treatment Mild PKU</brief_title>
	<detailed_description>PKU , phenylketonuria , rare , inherited metabolic disorder result mental retardation strict low-protein diet start within first week life . The conversion phenylalanine , phe , tyrosine defect , phe accumulates , lead brain damage . There different degree severity , reflect spectrum mutant gene . BH4 , tetrahydrobiopterin , co-enzym conversion phe tyrosine . It known BH4 low phe patient milder form PKU . The main purpose test whether treatment oral BH4 replace protein restrictive diet patient mild PKU cause frequent mutation Y414C phenylalanine hydroxylase gene .</detailed_description>
	<mesh_term>Phenylketonurias</mesh_term>
	<criteria>Diagnosed mild PKU 2 know mutation PAH gene , hereof least one Y414C From age eight Informed consent Less 8 year age Pregnancy treat intensive diet pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>mild PKU</keyword>
	<keyword>Y414C</keyword>
	<keyword>5,6,7,8-tetrahydrobiopterin , BH4</keyword>
	<keyword>treatment without protein restriction</keyword>
</DOC>